Lb Pharmaceuticals (LBRX) Cash from Operations (2024 - 2026)
Lb Pharmaceuticals (LBRX) posted quarterly Cash from Operations of 23300000.0 for Q1 2026, down 186.66% year-over-year from 26885633.16 in Q1 2025, and down 28.73% quarter-over-quarter from 18100000.0 in Q4 2025.
Powered by 
Analysis
Lb Pharmaceuticals (LBRX) Cash from Operations (2024 - 2026) Analysis & Trends
Lb Pharmaceuticals' Cash from Operations history runs 3 years deep, the most recent figure standing at 23300000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 186.66% year-over-year to 23300000.0; the TTM figure through Mar 2026 stood at 55193000.0 (changed N/A YoY), while the FY2025 annual figure was 35200000.0, up 33.65% from the prior year.
- Cash from Operations for Q1 2026 stood at 23300000.0, down from 18100000.0 in the prior quarter.
- The five-year high for Cash from Operations was 5665000.0 in Q4 2024, with the low at 23300000.0 in Q1 2026.
- The 3-year median for Cash from Operations is 13114000.0 (2025), against an average of 13798250.0.
- The sharpest annual moves came in 2025 and 2026: Cash from Operations plunged 219.51% in 2025, then sank 186.66% in 2026.
- Lb Pharmaceuticals' Cash from Operations stood at 5665000.0 in 2024, then slumped by 219.51% to 18100000.0 in 2025, then retreated by 28.73% to 23300000.0 in 2026.
- Business Quant data shows LBRX's Cash from Operations at 23300000.0 in Q1 2026, 18100000.0 in Q4 2025, and 8128000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Lb Pharmaceuticals | 1.49 Bn | 1.49 Bn | - | -37.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -37.62 Mn |
| Mar 31, 2026 | -23.30 Mn |
| Dec 31, 2025 | -18.10 Mn |
| Sep 30, 2025 | -3.37 Mn |
| Jun 30, 2025 | -5.60 Mn |
| Mar 31, 2025 | -8.13 Mn |
| Dec 31, 2024 | -5.67 Mn |